Literature DB >> 27561633

Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases.

Daniela Molena1, Francisco Schlottmann2, Joshua A Boys3, Shanda H Blackmon4, Karen J Dickinson4, Christy M Dunst5, Wayne L Hofstetter6, Michal J Lada7, Brian E Louie8, Benedetto Mungo9, Thomas J Watson7, Steven R DeMeester3.   

Abstract

BACKGROUND: Despite the increased risk for nodal disease, definitive endoscopic resection is being increasingly offered for lesions invasive into the submucosa based on the success with intramucosal tumors. The aim of this study was to evaluate survival after esophagectomy alone for confirmed submucosal tumors after endoscopic resection.
METHODS: Patients from seven centers in the USA who underwent esophagectomy for submucosal tumors removed with endoscopic resection were analyzed. Nodal involvement was correlated with recurrence and survival.
RESULTS: We identified 23 patients with submucosal esophageal adenocarcinoma. Esophagectomy was performed at a median of 2 months (Interquartile range 1-3) after the endoscopic resection. There was no postoperative mortality. Positive nodal disease was seen in 26 % of patients on final pathology. At a median of 37 months (Interquartile range 25-55), 91 % of patients were alive and free of disease. The disease-specific 5-year survival was 88 %. Disease-specific 5-year survival was 67 % in patients with positive nodal metastases and 100 % in those without (p = 0.159).
CONCLUSIONS: Esophagectomy is curative in the majority of patients with submucosal tumors even in the presence of nodal metastases. These data serve as a benchmark for comparison when considering extending the indications for therapeutic endoscopic resection for submucosal tumors in the future.

Entities:  

Keywords:  Endoscopic therapy; Esophageal cancer; Esophagectomy; T1b adenocarcinoma

Mesh:

Year:  2016        PMID: 27561633     DOI: 10.1007/s11605-016-3210-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  38 in total

1.  Pathologic lymph node ratio is a predictor of survival in esophageal cancer.

Authors:  Castigliano M Bhamidipati; George J Stukenborg; Christopher J Thomas; Christine L Lau; Benjamin D Kozower; David R Jones
Journal:  Ann Thorac Surg       Date:  2012-05-22       Impact factor: 4.330

2.  Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.

Authors:  Attila Dubecz; Marcus Kern; Norbert Solymosi; Michael Schweigert; Hubert J Stein
Journal:  Ann Thorac Surg       Date:  2015-04-28       Impact factor: 4.330

3.  The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.

Authors:  Jessica M Leers; Steven R DeMeester; Arzu Oezcelik; Nancy Klipfel; Shahin Ayazi; Emmanuele Abate; Jörg Zehetner; John C Lipham; Linda Chan; Jeffrey A Hagen; Tom R DeMeester
Journal:  Ann Surg       Date:  2011-02       Impact factor: 12.969

4.  Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.

Authors:  Traves D Crabtree; Wael N Yacoub; Varun Puri; Riad Azar; Jennifer Bell Zoole; G Alexander Patterson; A Sasha Krupnick; Daniel Kreisel; Bryan F Meyers
Journal:  Ann Thorac Surg       Date:  2011-03-24       Impact factor: 4.330

5.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

6.  Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus.

Authors:  Michael F Nentwich; Katharina von Loga; Matthias Reeh; Faik G Uzunoglu; Andreas Marx; Jakob R Izbicki; Dean Bogoevski
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

7.  Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma.

Authors:  Magali Cabau; Guillaume Luc; Eric Terrebonne; Geneviève Belleanne; Véronique Vendrely; Antonio Sa Cunha; Denis Collet
Journal:  Am J Surg       Date:  2013-02-16       Impact factor: 2.565

8.  Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.

Authors:  Rami J Badreddine; Ganapathy A Prasad; Jason T Lewis; Lori S Lutzke; Lynn S Borkenhagen; Kelly T Dunagan; Kenneth K Wang
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11-27       Impact factor: 11.382

9.  Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion.

Authors:  Hendrik Manner; Oliver Pech; Yvonne Heldmann; Andrea May; Juergen Pohl; Angelika Behrens; Liebwin Gossner; Manfred Stolte; Michael Vieth; Christian Ell
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-26       Impact factor: 11.382

10.  Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.

Authors:  Nasser K Altorki; Paul C Lee; Yaakov Liss; Danish Meherally; Robert J Korst; Paul Christos; Madhu Mazumdar; Jeffrey L Port
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

View more
  14 in total

Review 1.  Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium.

Authors:  Jon C Gould; Mark R Wendling; Brant K Oeschlager; Sumeet K Mittal; Srinadh Komanduri; Kyle A Perry; Sean Cleary; Susan Galandiuk; Daniel J Scott; P Marco Fisichella; Nicholas J Shaheen; Kelly R Haisley; John G Hunter
Journal:  J Gastrointest Surg       Date:  2017-02-27       Impact factor: 3.452

Review 2.  Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer.

Authors:  Francisco Schlottmann; Marco G Patti; Nicholas J Shaheen
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

3.  Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.

Authors:  Patrick Sven Plum; Arnulf Heinrich Hölscher; Kristin Pacheco Godoy; Henner Schmidt; Felix Berlth; Seung-Hun Chon; Hakan Alakus; Elfriede Bollschweiler
Journal:  Surg Endosc       Date:  2018-03-13       Impact factor: 4.584

Review 4.  Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia.

Authors:  Francisco Schlottmann; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2017-03-28       Impact factor: 3.452

5.  Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer.

Authors:  Hiroshi Miyata; Keijirou Sugimura; Takeshi Kanemura; Tomohira Takeoka; Masaaki Yamamoto; Naoki Shinno; Hisashi Hara; Takeshi Omori; Sachiko Yamamoto; Ryu Ishihara; Hiroshi Wada; Hidenori Takahashi; Junichi Nishimura; Chu Matsuda; Masayoshi Yasui; Masahiko Yano
Journal:  Ann Surg Oncol       Date:  2021-05-06       Impact factor: 5.344

6.  Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma.

Authors:  Wei Deng; Krishan R Jethwa; Karthik Gonuguntla; Zhongxing Liao; Harry H Yoon; Mariela Blum Murphy; Michael G Haddock; Christopher L Hallemeier; Steven H Lin
Journal:  Adv Radiat Oncol       Date:  2020-04-27

Review 7.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

8.  Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis.

Authors:  Jacqueline N Chu; Jin Choi; Angela Tramontano; Christopher Morse; David Forcione; Norman S Nishioka; Julian A Abrams; Joel H Rubenstein; Chung Yin Kong; John M Inadomi; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2017-11-24       Impact factor: 13.576

9.  Long-Term Survival and Tumor Recurrence in Patients with Superficial Esophageal Cancer after Complete Non-Curative Endoscopic Resection: A Single-Center Case Series.

Authors:  Ji Wan Lee; Charles J Cho; Do Hoon Kim; Ji Yong Ahn; Jeong Hoon Lee; Kee Don Choi; Ho June Song; Sook Ryun Park; Hyun Joo Lee; Yong Hee Kim; Gin Hyug Lee; Hwoon-Yong Jung; Sung-Bae Kim; Jong Hoon Kim; Seung-Il Park
Journal:  Clin Endosc       Date:  2018-06-01

10.  Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer.

Authors:  Solène Dermine; Mahaut Leconte; Sarah Leblanc; Bertrand Dousset; Benoit Terris; Arthur Berger; Anne Berger; Gabriel Rahmi; Vincent Lepilliez; Olivier Plomteux; Philippe Leclercq; Romain Coriat; Stanislas Chaussade; Frédéric Prat; Maximilien Barret
Journal:  Therap Adv Gastroenterol       Date:  2019-12-08       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.